Why did GAAP earnings decline while Operating EBITDA and Operating EPS increased?

GAAP income from continuing operations fell 12% in Q2 to $1.22B because of separation costs ($79M in Q2), significant items charges ($85M, including litigation settlements), higher amortization of intangibles, and unfavorable other income/expense including foreign exchange losses. Operating EBITDA and Operating EPS exclude these items, along with depreciation, interest, and certain non-operating costs, so they rose 4% and 5%, respectively.

What is driving the change in guidance and what risks are embedded in it?

Management raised 2026 guidance to reflect strong first-half execution, controllable cost and productivity levers, and growth from licensing and new products. The guidance includes a $25M separation-related dis-synergy headwind. Management notes that trade policy, currency movements, and weather could still affect results, and the company does not provide a GAAP reconciliation for its forward-looking non-GAAP measures.

What should investors understand about the Vylor separation?

Corteva plans to separate into two companies effective October 1, 2026, with Vylor spun off as an independent public company. Vylor is presented as continuing operations in the Form 10, while the new Corteva is shown as discontinued operations. Remaining milestones in the second half include final board-approved capital structures, Form 10 effectiveness, and a September 15, 2026 Investor Day. Net dis-synergies are said to be largely offset on a run-rate basis.

Is Corteva's balance sheet or liquidity position a concern?

Short-term borrowings increased to $3.19B at June 30, 2026, from $0.89B at December 31, 2025, and cash declined to $2.37B from $4.52B. Operating cash flow from continuing operations was negative $3.35B in the first half, primarily reflecting a seasonal decline in deferred revenue of $3.19B and $1.14B of pension and OPEB contributions. These patterns are typical of Corteva's seasonal cycle, but investors should monitor how the company rebuilds cash in the second half and how the separation affects its capital structure.

What drove the performance differences between Seed and Crop Protection?

Seed benefited from price/mix gains of 3% (demand for premium technologies and increased out-licensing income) and cost reductions, which lifted segment EBITDA 6% in Q2 despite a 3% volume decline. Crop Protection faced a 4% price decline, mainly from competitive pricing in Latin America, and a 2% volume decline tied to North American channel timing. Its segment EBITDA still rose 2% in Q2 due to cost and productivity actions and favorable currency.

CTVA 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed July 30, 2026. Cited figures are marked; the original filing is the authoritative source.

Corteva (CTVA) reported second-quarter 2026 results on July 30, 2026, showing a mixed but generally solid picture.

Net sales for the quarter were $6.38 billion^a, down 1% year over year (organic sales down 2%), while GAAP income from continuing operations fell 12% to $1.22 billion and GAAP EPS was $1.81. Operating EBITDA, the company's key non-GAAP profitability measure, rose 4% to $2.26 billion, with margin expanding by more than 190 basis points, and Operating EPS increased 5% to $2.30. Seed was flat in the quarter, with price/mix up 3% offset by a 3% volume decline, while Crop Protection sales fell 4% on lower price and volume, though its segment EBITDA rose 2% on cost actions.

For the first half of 2026, net sales rose 4% to $11.28 billion^b (organic +2%), Operating EBITDA grew 10% to $3.70 billion, and Operating EPS rose 14% to $3.80. Management raised full-year 2026 guidance, now calling for Operating EBITDA of $4.1 to $4.3 billion (about 9% growth at the midpoint) and Operating EPS of $3.60 to $3.80. The company also reaffirmed that the planned separation remains on track for an October 1, 2026 spin-off of Vylor, with a $25 million separation-related dis-synergy headwind included in guidance.

Investors should weigh the strong margin and earnings-quality improvement against some items that merit attention: GAAP earnings are pressured by separation costs ($131 million^c in the first half), a $262 million pre-tax significant items charge (including litigation settlements tied to FTC-related lawsuits), and a sharp increase in short-term borrowings to $3.19 billion. Operating cash flow from continuing operations was negative $3.35 billion for the first half, driven largely by a $3.19 billion decline in deferred revenue and $1.14 billion in pension contributions, which is seasonal but worth monitoring.

02—Key points

Key Highlights

Q2 2026 net sales of $6.38B declined 1% (organic -2%), with Seed flat at $4.53B and Crop Protection down 4% to $1.85B.
Q2 Operating EBITDA rose 4% to $2.26B with over 190 bps of margin expansion; Operating EPS rose 5% to $2.30 versus GAAP EPS of $1.81.
First-half 2026 Operating EBITDA grew 10% to $3.70B and Operating EPS grew 14% to $3.80, driven by price/mix in Seed and royalty/cost actions.
Full-year 2026 guidance raised: Operating EBITDA $4.1–$4.3B and Operating EPS $3.60–$3.80, implying roughly 9% and 11% growth at the midpoint.
Separation on track for October 1, 2026 spin-off of Vylor; key milestones include Form 10 effectiveness and a September 15, 2026 Investor Day at the NYSE.
Q2 GAAP results were weighed by $79M of separation costs and $85M of significant items, including litigation settlement charges tied to FTC-related lawsuits.
Short-term borrowings rose to $3.19B from $0.89B at year-end 2025, while cash fell to $2.37B, and first-half operating cash flow was negative $3.35B on seasonal working-capital and pension outflows.

03—Questions

Frequently Asked Questions

Why did GAAP earnings decline while Operating EBITDA and Operating EPS increased?
GAAP income from continuing operations fell 12% in Q2 to $1.22B because of separation costs ($79M in Q2), significant items charges ($85M, including litigation settlements), higher amortization of intangibles, and unfavorable other income/expense including foreign exchange losses. Operating EBITDA and Operating EPS exclude these items, along with depreciation, interest, and certain non-operating costs, so they rose 4% and 5%, respectively.
What is driving the change in guidance and what risks are embedded in it?
Management raised 2026 guidance to reflect strong first-half execution, controllable cost and productivity levers, and growth from licensing and new products. The guidance includes a $25M separation-related dis-synergy headwind. Management notes that trade policy, currency movements, and weather could still affect results, and the company does not provide a GAAP reconciliation for its forward-looking non-GAAP measures.
What should investors understand about the Vylor separation?
Corteva plans to separate into two companies effective October 1, 2026, with Vylor spun off as an independent public company. Vylor is presented as continuing operations in the Form 10, while the new Corteva is shown as discontinued operations. Remaining milestones in the second half include final board-approved capital structures, Form 10 effectiveness, and a September 15, 2026 Investor Day. Net dis-synergies are said to be largely offset on a run-rate basis.
Is Corteva's balance sheet or liquidity position a concern?
Short-term borrowings increased to $3.19B at June 30, 2026, from $0.89B at December 31, 2025, and cash declined to $2.37B from $4.52B. Operating cash flow from continuing operations was negative $3.35B in the first half, primarily reflecting a seasonal decline in deferred revenue of $3.19B and $1.14B of pension and OPEB contributions. These patterns are typical of Corteva's seasonal cycle, but investors should monitor how the company rebuilds cash in the second half and how the separation affects its capital structure.
What drove the performance differences between Seed and Crop Protection?
Seed benefited from price/mix gains of 3% (demand for premium technologies and increased out-licensing income) and cost reductions, which lifted segment EBITDA 6% in Q2 despite a 3% volume decline. Crop Protection faced a 4% price decline, mainly from competitive pricing in Latin America, and a 2% volume decline tied to North American channel timing. Its segment EBITDA still rose 2% in Q2 due to cost and productivity actions and favorable currency.

04—Continue

← View all 8-K filings